加味四逆散对肝硬化大鼠胃肠动力变化干预作用实验研究
|
摘要
目的：
研究加味四逆散对肝硬化大鼠胃肠动力障碍防治作用，并对其机制进行初步探讨。通过加味四逆散对肝硬化大鼠一般情况、肝功能、肝脏形态的疗效观察，对肝硬化大鼠胃电图异常的防治作用，从胃肠肽角度探讨实验性肝硬化大鼠胃肠动力紊乱的机制以及加味四逆散防治作用。以ICC(Interstitial cells of Cajal，Cajal间质细胞)表达c-kit(Ⅲ型跨膜蛋白酪氨酸激酶生长因子受体蛋白)为切入点，研究肝硬化大鼠的c-kit表达量变化，以及加味四逆散对其的影响，以GASR(胃泌素受体)、VIPR2(VIP-2 receptor，血管活性肠肽Ⅱ型受体)为代表，在胃肠组织对胃肠肽受体水平测定探讨肝硬化大鼠胃肠动力信号接收系统变化，探讨加味四逆散治疗机理。
方法：
Wister雄性大鼠48只被随机分为4组，每组12只，除空白组外，其他三组均给予大鼠皮下注射40％CCL_4花生油溶液2．5ml／kg，每周2次造模，连续造模11周。第八周造模同时中药组用“加味四逆散”煎剂灌胃治疗，西药组以西沙比利灌胃治疗，空白、模型组则给予等体积生理盐水灌胃。于11周末检测大鼠胃电图、肝功能、肝组织病理；放免法测定血清、胃、小肠的MTL(Motilin，胃动素)、GAS(gastrin，胃泌素)、VIP(Vosoactiveintestinepoly Peptide，血管活性肠肽)、SS(somatostatins，生长抑素)含量变化。免疫组化法测定胃组织GAS、SS，小肠组织MTL、VIP含量变化；免疫组化法测定胃组织c-kit阳性表达量变化；RT—PCR(Rever se Transcription Polymerase Chain Reaction，逆转录聚合酶联反应)法测定胃组织GASR、空肠组织VIPR2两种受体mRNA的表达及定量分析，检测完毕后对空白组、模型组、西药组及中药组相应数据分别进行统计学分析。
结果：
(1)模型组一般情况、肝功能、肝脏形态与空白组相比均有显著性差异(P＜0．01或P＜0．05)，加味四逆散组与模型组比较肝功能TP(total protein，总蛋白)、ALB(albumin，白蛋白)含量明显升高，ALT(alaninetransamina se，谷丙转氨酶)、AST(aspartate transaminase天冬氨酸转氨酶)含量明显下降，均有显著性差异(P＜0．01或P＜0．05)；肝组织病理改变明显减轻；“加味四逆散”组与西药组比较：肝功能TP、ALB含量明显升高，ALT、AST含量明显下降，均有显著性差异(P＜0．01、P＜0．01或P＜0．05)，肝组织病理改变减轻。
(2)模型组慢波节律、主功率、主频率、快波频率明显低于正常组(P＜0．05、P＜0．01)，胃电慢波振幅无明显改变；中药组慢波节律、主频率、主功率、快波频率与模型组比较明显增强(P＜0．05、P＜0．01)，胃电慢波振幅无明显改变，胃电波接近正常对照水平，与西药组比较慢波节律及快波频率均有明显差异(P＜0．05、P＜0．01)；西药组主频率、快波频率与模型组比较明显增强(P＜0．05)，主功率、慢波节律与模型组比较无明显差异(P＞0．05)。
(3)放免法测定，模型组与空白对照组比较，模型组大鼠血浆及胃肠组织中GAS、SS、MTL、VIP的含量均明显增加(P＜0．01或P＜0．05)；中药组与模型组比较，中药组大鼠血浆及胃组织中GAS、SS、MTL、VIP的含量明显降低(P＜0．01或P＜0．05)，肠组织中MTL、SS、VIP的含量明显降低(P＜0．01或P＜0．05)，肠组织中GAS的含量无明显降低(P＞0．05)。中药组与西药组比较血浆MTL升高明显(P＜0．05)，VIP明显降低(P＜0．01)，GAS、SS无明显差异(P＞0．05)，胃组织中GAS含量明显升高(P＜0．01)，VIP的含量明显降低(P＜0．05)，MTL、SS的含量无明显差距(P＞0．05)，肠组织中GAS的含量明显升高(P＜0．05)，SS的含量明显降低(P＜0．05)MTL、VIP的含量无明显差异(P＞0．05)但有不同程度升高或降低；西药组与模型组比较大鼠血浆MTL、VIP、SS的含量明显降低(P＜0．01或P＜0．05)，GAS接近(P＞0．05)，胃组织中MTL、GAS、SS、VIP明显降低(P＜0．05)，肠组织中MTL、GAS、VIP明显降低(P＜0．05)，SS接近(P＞0．05)。免疫组化法测定，模型组与空白组比较大鼠胃肠组织中GAS、SS、MTL、VIP的含量明显升高(P＜0．05)。中药组与模型组比较大鼠胃肠组织中GAS、SS、MTL、VIP的含量明显降低(P＜0．05)，与西药组比较胃肠组织中GAS、SS、MTL、VIP的含量接近，无明显差异(P＜0．05)；西药组与模型组比较大鼠胃肠组织中GAS、MTL、VIP的含量明显降低(P＜0．05)，SS接近。
(4)各组胃组织c-kit均有阳性表达，肝硬化组与对照组相比c-kit量明显降低(P＜0．05)。中药组的阳性表达量与肝硬化组比较明显升高(P＜0．05)，接近空白组，与西药组比较明显升高(P＜0．05)。西药组与模型组比较阳性表达量无显著差异(P＞0．05)。
(5)各组在胃组织中GAS受体mRNA均有表达，肝硬化组在胃组织GASRmRNA表达与空白组相比含量明星降低(P＜0．01)；中药组与肝硬化组比较含量明显升高(P＜0．01)与西药组比较明显升高(P＜0．05)，。在空肠各组VIPR2受体mRNA均有表达，肝硬化组与空白组相比VIPR2mRNA含量升高(P＜0．01)，中药组与组肝硬化VIPR2mRNA含量明显降低(P＜0．01)，与西药组比较明显降低(P＜0．05)。
结论：
本实验得出以下结论，(1)加味四逆散：显著提高TP、ALB含量，降低ALT、AST含量。因此，加味四逆散能有效地保护肝细胞，恢复肝功能，具有较好的防治实验大鼠肝硬化病理改变的作用。(2)加味四逆散能够明显改善实验性肝硬化大鼠的胃电波异常，从而有明显促胃动力作用。(3)肝硬化大鼠血浆、胃、小肠不同部位的GAS、SS、MTL、VIP的变化方向基本一致，但程度不一。可能与肝硬化时肝脏灭活胃肠激素功能减退有关。加味四逆散对实验性肝硬化大鼠胃肠肽分泌异常有一定调节作用。(4)肝硬化大鼠胃c-kit含量明显降低、加味四逆散具有增加c-kit阳性ICC作用。(5)GAS、VIP2受体在胃肠道分布差异可能与肝硬化所致胃肠道动力紊乱表现有一定关系，加味四逆散对肝硬化大鼠胃肠肽受体水平的异常有调节作用。
Object:to study how Supplemented Sini powdercan cure rats withliver cirrhosis with gastric motility dysfunction and probe itsmechanism preliminarily by liver function、liver tissuepathology.research of Jiawei Sinisans's prophylaxis the big rats electrogastrograms with liver cirrhosis and conduct a preliminary probe.toprobe into the signal conduction dysfunction of experimental ratscaused by liver cirrhosis with gastric motility dysfunction fromgastrointestinal peptide signal cell level and Supplemented Sinipowdertherapymechanism.touseICC to express c-kit and set it asthe point of entry to study the c-kit change of rats with livercirrhosis and the influence of Jiawei Sinisan,and expecting toexplain partly mechanism how the liver cirrhosis gastric motilitydysfunction happens,using GAS、VIP2receptorsasrepresentatives,to detect the signal receiving system change in gastrointestinalpeptide smooth muscle cells receptor level,and probe into therapycure mechanism of the Jiawei Sinisan.
Method:We divide 48 Wister male big rats into 4 groups randomlyand each group has 12 rats,then inject the other 3 groups with40%C C 1_4peanut oil solution with concentration of 2.5ml/kg except blank group,and construct model twice every week and continuouslyfor 11 weeks.After the construction of 4 weeks,using SupplementedSini powderto do gastric perfusion therapy to cure the traditionalChinese medicine group,western group with cisapride gastricperfusion therapy,bank group and model group with physiologicalsaline of the same volume.After 11 weeks,testing all the rats's electrogastrograms、liver function、liver tissue pathology.detect the content changes of MTL、GAS、VIP、SS in serum、gastric、small intestines by radiation immunological.Detect gastrictissue' GAS、SS、c-kit and small intestines' MTL、VIP contentchanges by immunohistochemical technique.detecting the gastricGASR and the jejunum these two receptors' distribution andquantitative analysis by RT-PCR technique.After the test,doingstatistics comparison to the data of traditional Chinese medicinegroup、bank group、modeling group and western medicine group.
Results:
(1)Rats in normal situation、liver function、liver histolomorphof liver cirrhosis group all had evident differents compared to theblank group(P＜0.01 or P＜0.05).comparison of Supplemented Sinipowdergrouptomodelinggroup:liver function' s TP and ALB contentsincreased obviously,while ALT and AST contents decreased evidentlyand had obvious discrepancies(P＜0.01 or P＜0.05);Liver tissuepathology change alleviated apparently.Comparison of SupplementedSini powdergroup to western medicine group:liver function' s TPand ALB increasedobviously,while ALT、ASTdecreasedevidentlyandhad obvious discrepancies(P＜0.01 or P＜0.05);Liver tissuepathology change alleviated;Supplemented Sini powdergroup' selectrogastrograms was close to normal while western group' s electrogastrograms the amplitude of vibration had slight recover.
(2)Modelinggroup' s slow wave rhythm、main frequency、mainpower and fast wave is lower than normal group obviously(P＜0.05orP＜0.01),and have no obvious change of electrogastrogramamplitude of vibration at gastric antrum(P＞0.05);The traditionalChinese medicine group' s slow wave rhythm、main frequency、mainpower and fast wave are bigger than the modeling group(P＜0.05 orP＜0.01),and close to the normal comparison level(P＞0.05),andamplitude of vibration has no evident change than the modeling group(P＞0.05),slow wave rhythm and fast wave are bigger than thewestern medicine group'(P＜0.05orP＜0.01);the'smainfrequencyand fast wave are bigger than the modeling group(P＜0.05),westernmedicine group main power and slow wave rhythm has no evident changethan the modeling group(P＞0.05)
(3)To test MTL、GAS、VIP、SS by radiation immunological,theGAS、SS、MTL、VIPcontent inblood、gastric and intestines of livercirrhosis group all had evident increases compared to the bankgroup(P＜0.01orP＜0.05),theGAS、SS、MTL、VIPcontent in blood andgastric of Chinese traditional medicine group all had evidentdecreases compared to the liver cirrhosis group(P＜0.01orP＜0.05),MTL、SS、VIP content in intestines had evident decreases(P＜0.01orP＜0.05),GAS content in intestines had no evidentdecreases(P＞0.05),MTL content in blood had evident increasescompared to the modeling group(P＜0.05),VIPhadevident decreases(P＜0.01),GAS、SS had no evident different(P＞0.05),but haddifferent level of increase or decrease.GAS content in gastric hadevident increases(P＜0.01orP＜0.05),VIP had evident decreases,MTL、SS had no evident different(P＞0.05).GAS in intestines had evident increases(P＜0.05),SShadevidentdecreases(P＜0.05),MTL、VIP hadno evident different(P＞0.05).the GAS、MTL、VIPcontent in bloodand gastric of Chinese traditional medicine group all had evidentdecreases compared to the liver cirrhosis group(P＜0.01orP＜0.05),SShad no evident different(P＞0.05).the GAS、SS、MTL、VIP contentin gastric and intestines of the liver cirrhosis detected byimmunohistochemical technique had obvious increases compared tothe comparison group(P＜0.05),The GAS、SS、MTL、VIP content ingastric and intestines of the Chinese traditional medicine groupall had evident decreases compared to the liver cirrhosis group(P＜0.05),And theMTL、GAS、SS、VIPwas close to the the westernmedicine group,TheGAS、MTL、VIPcontent in gastric and intestinesof the western medicine group all had evident decreases comparedto the liver cirrhosis group(P＜0.05),SS、had no evident different(P＞0.05).
(4)In different levels of gastric,c-kit Mean optical density(MOD)and positive area percentage of liver cirrhosis group all hadobvious decreases compared to the comparison group(P＜0.05).Meanoptical density and positive area percentage of the Chinesetraditional medicine group all increased evidently(P＜0.05),andhad no obvious discrepancies to the comparison group.Mean opticaldensity and positive area percentage of the western medicine groupall decreased evidently(P＜0.05),and had no obvious discrepanciesto the modeling group(P＞0.05).
(5)All groups had GAS receptor mRNA expression in gastricantrum,and liver cirrhosis group had obvious decreases of GASRmRNAexpression compared to the normal group(P＜0.01);the Chinesetraditional medicine group had evidently increase of GASRmRNA expression compared to the liver cirrhosis group(P＜0.05),hadevidently increase of GASRmRNA expression compared to the westernmedicine group(P＜0.05),and had no obvious discrepancies comparedto the normal group(P＞0.05).All groups hadVIPR2 receptor mRNAexpression in the jejunum,and liver cirrhosis had a higherVIPR2mRNA content than the comparison group(P＜0.01),and theChinese traditional medicine group obviously had a lower VIPR2mRNAcontent than the liver cirrhosis group(P＜0.01).had a lowerVIPR2mRNA content than the western medicine group(P＜0.05).
Conclusion:
(1)Supplemented Sini powderevident increases of TP and ALBcontents and decreased of ALT and AST content.So,Supplemented Sinipowdercan effectively protect liver cells,recover liver function,and has a good cure of experiment rats' liver cirrhosis andameliorates Gastric motility function
(2)Jiawei Sinisans can better experimental rats' electrogastrogram wave dysfunction evidently and promote gastric motility
(3)In gastrointestinal peptide signal cell level,GAS、SS、MTL、VIP in blood、gastric and intestines of rats with livercirrhosis had nearly the same change direction,but different inlevel.It maybe relate to liver cirrhosis gastric motilitydysfunction、malabsorption、ascites,etc.Supplemented Sinipowderhad some therapy cure to the experimental liver cirrhosisrats with gastrointestinal peptide parasecretion.
(4)Gastric c-kit content in rats liver cirrhosis had evidentdecreased,and Supplemented Sini powdermay have the function ofincreasing c-kit positive ICC.
(5)GAS and VIP receptors having different distributions in gastrointestinal tract may have some relationship to the differentgastric motility dysfunction expression caused by liver cirrhosis.Supplemented Sini powderhad a therapy cure to disnormalgastrointestinal peptide receptor level of rats with livercirrhosis.
研究加味四逆散对肝硬化大鼠胃肠动力障碍防治作用，并对其机制进行初步探讨。通过加味四逆散对肝硬化大鼠一般情况、肝功能、肝脏形态的疗效观察，对肝硬化大鼠胃电图异常的防治作用，从胃肠肽角度探讨实验性肝硬化大鼠胃肠动力紊乱的机制以及加味四逆散防治作用。以ICC(Interstitial cells of Cajal，Cajal间质细胞)表达c-kit(Ⅲ型跨膜蛋白酪氨酸激酶生长因子受体蛋白)为切入点，研究肝硬化大鼠的c-kit表达量变化，以及加味四逆散对其的影响，以GASR(胃泌素受体)、VIPR2(VIP-2 receptor，血管活性肠肽Ⅱ型受体)为代表，在胃肠组织对胃肠肽受体水平测定探讨肝硬化大鼠胃肠动力信号接收系统变化，探讨加味四逆散治疗机理。
方法：
Wister雄性大鼠48只被随机分为4组，每组12只，除空白组外，其他三组均给予大鼠皮下注射40％CCL_4花生油溶液2．5ml／kg，每周2次造模，连续造模11周。第八周造模同时中药组用“加味四逆散”煎剂灌胃治疗，西药组以西沙比利灌胃治疗，空白、模型组则给予等体积生理盐水灌胃。于11周末检测大鼠胃电图、肝功能、肝组织病理；放免法测定血清、胃、小肠的MTL(Motilin，胃动素)、GAS(gastrin，胃泌素)、VIP(Vosoactiveintestinepoly Peptide，血管活性肠肽)、SS(somatostatins，生长抑素)含量变化。免疫组化法测定胃组织GAS、SS，小肠组织MTL、VIP含量变化；免疫组化法测定胃组织c-kit阳性表达量变化；RT—PCR(Rever se Transcription Polymerase Chain Reaction，逆转录聚合酶联反应)法测定胃组织GASR、空肠组织VIPR2两种受体mRNA的表达及定量分析，检测完毕后对空白组、模型组、西药组及中药组相应数据分别进行统计学分析。
结果：
(1)模型组一般情况、肝功能、肝脏形态与空白组相比均有显著性差异(P＜0．01或P＜0．05)，加味四逆散组与模型组比较肝功能TP(total protein，总蛋白)、ALB(albumin，白蛋白)含量明显升高，ALT(alaninetransamina se，谷丙转氨酶)、AST(aspartate transaminase天冬氨酸转氨酶)含量明显下降，均有显著性差异(P＜0．01或P＜0．05)；肝组织病理改变明显减轻；“加味四逆散”组与西药组比较：肝功能TP、ALB含量明显升高，ALT、AST含量明显下降，均有显著性差异(P＜0．01、P＜0．01或P＜0．05)，肝组织病理改变减轻。
(2)模型组慢波节律、主功率、主频率、快波频率明显低于正常组(P＜0．05、P＜0．01)，胃电慢波振幅无明显改变；中药组慢波节律、主频率、主功率、快波频率与模型组比较明显增强(P＜0．05、P＜0．01)，胃电慢波振幅无明显改变，胃电波接近正常对照水平，与西药组比较慢波节律及快波频率均有明显差异(P＜0．05、P＜0．01)；西药组主频率、快波频率与模型组比较明显增强(P＜0．05)，主功率、慢波节律与模型组比较无明显差异(P＞0．05)。
(3)放免法测定，模型组与空白对照组比较，模型组大鼠血浆及胃肠组织中GAS、SS、MTL、VIP的含量均明显增加(P＜0．01或P＜0．05)；中药组与模型组比较，中药组大鼠血浆及胃组织中GAS、SS、MTL、VIP的含量明显降低(P＜0．01或P＜0．05)，肠组织中MTL、SS、VIP的含量明显降低(P＜0．01或P＜0．05)，肠组织中GAS的含量无明显降低(P＞0．05)。中药组与西药组比较血浆MTL升高明显(P＜0．05)，VIP明显降低(P＜0．01)，GAS、SS无明显差异(P＞0．05)，胃组织中GAS含量明显升高(P＜0．01)，VIP的含量明显降低(P＜0．05)，MTL、SS的含量无明显差距(P＞0．05)，肠组织中GAS的含量明显升高(P＜0．05)，SS的含量明显降低(P＜0．05)MTL、VIP的含量无明显差异(P＞0．05)但有不同程度升高或降低；西药组与模型组比较大鼠血浆MTL、VIP、SS的含量明显降低(P＜0．01或P＜0．05)，GAS接近(P＞0．05)，胃组织中MTL、GAS、SS、VIP明显降低(P＜0．05)，肠组织中MTL、GAS、VIP明显降低(P＜0．05)，SS接近(P＞0．05)。免疫组化法测定，模型组与空白组比较大鼠胃肠组织中GAS、SS、MTL、VIP的含量明显升高(P＜0．05)。中药组与模型组比较大鼠胃肠组织中GAS、SS、MTL、VIP的含量明显降低(P＜0．05)，与西药组比较胃肠组织中GAS、SS、MTL、VIP的含量接近，无明显差异(P＜0．05)；西药组与模型组比较大鼠胃肠组织中GAS、MTL、VIP的含量明显降低(P＜0．05)，SS接近。
(4)各组胃组织c-kit均有阳性表达，肝硬化组与对照组相比c-kit量明显降低(P＜0．05)。中药组的阳性表达量与肝硬化组比较明显升高(P＜0．05)，接近空白组，与西药组比较明显升高(P＜0．05)。西药组与模型组比较阳性表达量无显著差异(P＞0．05)。
(5)各组在胃组织中GAS受体mRNA均有表达，肝硬化组在胃组织GASRmRNA表达与空白组相比含量明星降低(P＜0．01)；中药组与肝硬化组比较含量明显升高(P＜0．01)与西药组比较明显升高(P＜0．05)，。在空肠各组VIPR2受体mRNA均有表达，肝硬化组与空白组相比VIPR2mRNA含量升高(P＜0．01)，中药组与组肝硬化VIPR2mRNA含量明显降低(P＜0．01)，与西药组比较明显降低(P＜0．05)。
结论：
本实验得出以下结论，(1)加味四逆散：显著提高TP、ALB含量，降低ALT、AST含量。因此，加味四逆散能有效地保护肝细胞，恢复肝功能，具有较好的防治实验大鼠肝硬化病理改变的作用。(2)加味四逆散能够明显改善实验性肝硬化大鼠的胃电波异常，从而有明显促胃动力作用。(3)肝硬化大鼠血浆、胃、小肠不同部位的GAS、SS、MTL、VIP的变化方向基本一致，但程度不一。可能与肝硬化时肝脏灭活胃肠激素功能减退有关。加味四逆散对实验性肝硬化大鼠胃肠肽分泌异常有一定调节作用。(4)肝硬化大鼠胃c-kit含量明显降低、加味四逆散具有增加c-kit阳性ICC作用。(5)GAS、VIP2受体在胃肠道分布差异可能与肝硬化所致胃肠道动力紊乱表现有一定关系，加味四逆散对肝硬化大鼠胃肠肽受体水平的异常有调节作用。
Object:to study how Supplemented Sini powdercan cure rats withliver cirrhosis with gastric motility dysfunction and probe itsmechanism preliminarily by liver function、liver tissuepathology.research of Jiawei Sinisans's prophylaxis the big rats electrogastrograms with liver cirrhosis and conduct a preliminary probe.toprobe into the signal conduction dysfunction of experimental ratscaused by liver cirrhosis with gastric motility dysfunction fromgastrointestinal peptide signal cell level and Supplemented Sinipowdertherapymechanism.touseICC to express c-kit and set it asthe point of entry to study the c-kit change of rats with livercirrhosis and the influence of Jiawei Sinisan,and expecting toexplain partly mechanism how the liver cirrhosis gastric motilitydysfunction happens,using GAS、VIP2receptorsasrepresentatives,to detect the signal receiving system change in gastrointestinalpeptide smooth muscle cells receptor level,and probe into therapycure mechanism of the Jiawei Sinisan.
Method:We divide 48 Wister male big rats into 4 groups randomlyand each group has 12 rats,then inject the other 3 groups with40%C C 1_4peanut oil solution with concentration of 2.5ml/kg except blank group,and construct model twice every week and continuouslyfor 11 weeks.After the construction of 4 weeks,using SupplementedSini powderto do gastric perfusion therapy to cure the traditionalChinese medicine group,western group with cisapride gastricperfusion therapy,bank group and model group with physiologicalsaline of the same volume.After 11 weeks,testing all the rats's electrogastrograms、liver function、liver tissue pathology.detect the content changes of MTL、GAS、VIP、SS in serum、gastric、small intestines by radiation immunological.Detect gastrictissue' GAS、SS、c-kit and small intestines' MTL、VIP contentchanges by immunohistochemical technique.detecting the gastricGASR and the jejunum these two receptors' distribution andquantitative analysis by RT-PCR technique.After the test,doingstatistics comparison to the data of traditional Chinese medicinegroup、bank group、modeling group and western medicine group.
Results:
(1)Rats in normal situation、liver function、liver histolomorphof liver cirrhosis group all had evident differents compared to theblank group(P＜0.01 or P＜0.05).comparison of Supplemented Sinipowdergrouptomodelinggroup:liver function' s TP and ALB contentsincreased obviously,while ALT and AST contents decreased evidentlyand had obvious discrepancies(P＜0.01 or P＜0.05);Liver tissuepathology change alleviated apparently.Comparison of SupplementedSini powdergroup to western medicine group:liver function' s TPand ALB increasedobviously,while ALT、ASTdecreasedevidentlyandhad obvious discrepancies(P＜0.01 or P＜0.05);Liver tissuepathology change alleviated;Supplemented Sini powdergroup' selectrogastrograms was close to normal while western group' s electrogastrograms the amplitude of vibration had slight recover.
(2)Modelinggroup' s slow wave rhythm、main frequency、mainpower and fast wave is lower than normal group obviously(P＜0.05orP＜0.01),and have no obvious change of electrogastrogramamplitude of vibration at gastric antrum(P＞0.05);The traditionalChinese medicine group' s slow wave rhythm、main frequency、mainpower and fast wave are bigger than the modeling group(P＜0.05 orP＜0.01),and close to the normal comparison level(P＞0.05),andamplitude of vibration has no evident change than the modeling group(P＞0.05),slow wave rhythm and fast wave are bigger than thewestern medicine group'(P＜0.05orP＜0.01);the'smainfrequencyand fast wave are bigger than the modeling group(P＜0.05),westernmedicine group main power and slow wave rhythm has no evident changethan the modeling group(P＞0.05)
(3)To test MTL、GAS、VIP、SS by radiation immunological,theGAS、SS、MTL、VIPcontent inblood、gastric and intestines of livercirrhosis group all had evident increases compared to the bankgroup(P＜0.01orP＜0.05),theGAS、SS、MTL、VIPcontent in blood andgastric of Chinese traditional medicine group all had evidentdecreases compared to the liver cirrhosis group(P＜0.01orP＜0.05),MTL、SS、VIP content in intestines had evident decreases(P＜0.01orP＜0.05),GAS content in intestines had no evidentdecreases(P＞0.05),MTL content in blood had evident increasescompared to the modeling group(P＜0.05),VIPhadevident decreases(P＜0.01),GAS、SS had no evident different(P＞0.05),but haddifferent level of increase or decrease.GAS content in gastric hadevident increases(P＜0.01orP＜0.05),VIP had evident decreases,MTL、SS had no evident different(P＞0.05).GAS in intestines had evident increases(P＜0.05),SShadevidentdecreases(P＜0.05),MTL、VIP hadno evident different(P＞0.05).the GAS、MTL、VIPcontent in bloodand gastric of Chinese traditional medicine group all had evidentdecreases compared to the liver cirrhosis group(P＜0.01orP＜0.05),SShad no evident different(P＞0.05).the GAS、SS、MTL、VIP contentin gastric and intestines of the liver cirrhosis detected byimmunohistochemical technique had obvious increases compared tothe comparison group(P＜0.05),The GAS、SS、MTL、VIP content ingastric and intestines of the Chinese traditional medicine groupall had evident decreases compared to the liver cirrhosis group(P＜0.05),And theMTL、GAS、SS、VIPwas close to the the westernmedicine group,TheGAS、MTL、VIPcontent in gastric and intestinesof the western medicine group all had evident decreases comparedto the liver cirrhosis group(P＜0.05),SS、had no evident different(P＞0.05).
(4)In different levels of gastric,c-kit Mean optical density(MOD)and positive area percentage of liver cirrhosis group all hadobvious decreases compared to the comparison group(P＜0.05).Meanoptical density and positive area percentage of the Chinesetraditional medicine group all increased evidently(P＜0.05),andhad no obvious discrepancies to the comparison group.Mean opticaldensity and positive area percentage of the western medicine groupall decreased evidently(P＜0.05),and had no obvious discrepanciesto the modeling group(P＞0.05).
(5)All groups had GAS receptor mRNA expression in gastricantrum,and liver cirrhosis group had obvious decreases of GASRmRNAexpression compared to the normal group(P＜0.01);the Chinesetraditional medicine group had evidently increase of GASRmRNA expression compared to the liver cirrhosis group(P＜0.05),hadevidently increase of GASRmRNA expression compared to the westernmedicine group(P＜0.05),and had no obvious discrepancies comparedto the normal group(P＞0.05).All groups hadVIPR2 receptor mRNAexpression in the jejunum,and liver cirrhosis had a higherVIPR2mRNA content than the comparison group(P＜0.01),and theChinese traditional medicine group obviously had a lower VIPR2mRNAcontent than the liver cirrhosis group(P＜0.01).had a lowerVIPR2mRNA content than the western medicine group(P＜0.05).
Conclusion:
(1)Supplemented Sini powderevident increases of TP and ALBcontents and decreased of ALT and AST content.So,Supplemented Sinipowdercan effectively protect liver cells,recover liver function,and has a good cure of experiment rats' liver cirrhosis andameliorates Gastric motility function
(2)Jiawei Sinisans can better experimental rats' electrogastrogram wave dysfunction evidently and promote gastric motility
(3)In gastrointestinal peptide signal cell level,GAS、SS、MTL、VIP in blood、gastric and intestines of rats with livercirrhosis had nearly the same change direction,but different inlevel.It maybe relate to liver cirrhosis gastric motilitydysfunction、malabsorption、ascites,etc.Supplemented Sinipowderhad some therapy cure to the experimental liver cirrhosisrats with gastrointestinal peptide parasecretion.
(4)Gastric c-kit content in rats liver cirrhosis had evidentdecreased,and Supplemented Sini powdermay have the function ofincreasing c-kit positive ICC.
(5)GAS and VIP receptors having different distributions in gastrointestinal tract may have some relationship to the differentgastric motility dysfunction expression caused by liver cirrhosis.Supplemented Sini powderhad a therapy cure to disnormalgastrointestinal peptide receptor level of rats with livercirrhosis.
引文
[1]程明亮，杨长青．肝纤维化的基础研究及临床[M]．北京人民卫生出 版社．2002．9
[2]范云程，陈正言．胃动素测定在肝硬化诊断中的意义[J]．标记免疫分析与临床，2003， 10 (3) ：179
[3]Loui SH，Lemoine 0， Peny M0， et al．H， Lepatoprot active role of interleukin-10 in galactosamine／lipopolysac charide mouse liver injury [J]．Gastroenterology．1997， 112： 935-942．
[4]Rei tamo S， remi tz A， TamaiK， et al．Interleukin 10modulatestype Ⅰcollagen and matrix metal loprotease gene expression in cultured human skin fibro blasts [J]．Jclin Invest，1994， 94：2489-2492
[5]Gasso M， Rubio M， Varela G， et al．Effects of S-adenosylme-thionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis [J]．JHepatol，1996，25 (2)：200- 205．
[6]Rockey DC，Chung JJ．Endothelin antagonism in experimental hepatic fibrosis．Implication for endothelin in the pathogen es is of wound healing [J]．JClin Invest，1996， 98 (6)：1381-1388．
[7]Yu Q，Shao R，Qian HS， et al．Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hype r tens ion [J]．JClin Invest，2000， 105 (6)：741-748．[7]
[8]Beno DW，Mullen J， Davis BH．Lipoxygenase in hibitors block PDGF-induced mitogenesis：aMAPK-independentmechanism that block sfos and egr[J]．Am JPhysiol，1995，268 (3Pt1)：C604- C610．
[9]Levi tzki A， Gazi t A．Tyros ine kinase inhibi t ion： an approach to drug development [J]．Science，1995， 267 (5205)：1782-1788．
[10]Matsuda Y， Matsumoto K， Yamada A， et al．Preventive and thera peutic effect sinrats of hetocyte growth factor infusion on liver fibrosis／cirrhosis [J]．Hepatology， 1997，26(1)：81-89．
[11]Gandhi CR， Kuddu s R， Subbo t i n VM， e t a l．Afresh look at augmenter of liver regeneration in rats[J]．Hepatology， 1999， 29： 1435-1445．
[12]Ueki T， Kaneda Y，Tsutsui H， et al．Hepatocyte growth factor gene the rapy of liver fibrosis in rats [J]．Nat Med， 1999，5： 226-230．
[13]杨玲，抗纤软肝冲剂药物血清对激活肝星壮细胞表达I型前较原及TGF- β 1的影响[J]．中国中医基础医学杂志，2001； 7 (8)： 38
[14]王尊松．肝硬化患者体表胃电图参数与肝功能损害程度的相关性研究[J]．i临床肝胆病杂志，2005， 171， 6 (21)：171-173．
[15]Ljung T， Hellstrom PM．Vasoactive intestinal petide suppres smig ratingmyo-dectric ecomplex of rat small intestine independent of nitric oxide[J]．ActaPhysiol Scand， 1999，165 (2)：225-231．
[16]Foxx Orenstein A， Cami l leri M， Stephens D， et al．Effect of a somatostatinanalogue on gastric motor and sensory functions in healthy humans[J]．Gut， 2002， 52 (11)：1555-1561
[17]Deman JG， Chatter jee S， Dewinter BY， etal．Effect of somatostatin on gastrointestinal contractility in Schistosomamansoni infected mice [J]．Int JPar-asitol， 2002，32(10P1309-1320．
[18]魏尔清．药理学前沿一信号、蛋白因子、基因与现代药理．第1版[M]．北京：科学出版社，1999： 3-14
[19]Hanani M，Freund HR．interstitial cells of Cajal-their role in pacing and signal transmission in the digestive system[J]．Acta physiol Scand，2000：174：237-246
[20]Sanders KM， Tamas O， Koh SD， et al．A novel pacemarker mechanism drives gastrointestinal rhymicity[J]．News physiol Sci， 2000： 15： 291-298
[21]Vannunnhi MG．Receptors in interstitial cells of Cajal： Identification and possible physiological roles[J]．Microse Res Tech ．1999；47：325-335
[22]Huizing JD．Thuneberg L， Kluppep M， et al．w／kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity[J]．Nature．1995：373：347-349
[23]Komuro T， Tokui K，Zhou DS．Identification of the interstitial cells of Cajal[J]．Histopathol，1996： 11：769
[24]傅诚强 ．Cajal间质细胞控制肠动力的作用[J]，国外医学．外科学分册，1997：24(6)：323-325
[25]Sanders KM．A case for interstitial cells of Cajal as pacemakers and mediators of neurtroans mission in the gastro intestinal tract[J]．Gas troenterology， 1996： 111 (2) 492-515
[26]Plu ja L， Alberti E， Fernandez E，Mikkelsen HB，et al．Evidence supporting presence of two pace makers in rat colon[J]．Am J Physiol Gastrointest Liver Physiol，2001：281 (1)：6255-6266
[27]Wester T， Eriksson L， Olsson Y．et al．Interstital cells of Cajal in the human fetal small bowel as showm by c-kit immunohisto chemistry [J]．Gut，1999：44 (1)：65- 71
[28]Maeda H， Yamagata A， Nishikawa S， et al．Requirement of c-kit for development of intestinal pace maker system[J]．Devel opment，1992：116：369-375
[29]Kitamura Y，Hirotab S．Kit as a human oncogenic tyrosine kinase [J]．Cell Mol Life Sci，2004：61(23)：2924-2931
[30]Rumessen JJ，Vanderwinden JM．Interstitial cells in the muscula ture of the gastrointestinal tract：Ca jal and beyond [J]．Int Rev Cytol，2003：229：115-208
[31]周吕．胃肠动力与相关受体[M]．基础医学与临床2001； 21： 15
[32]Karoor V，Shih M．Tholanikunnel B，Malbon CC．Regulatingex Pression and function of G-Protein-linked receptors[J]．Prog Neurobiol 1996；48：555-568
[33]Malbon CC，Berrios M，Guest SJ．Signal transduction via G-Protein-linked receptors： Physiological regulation from the plasma membrane to the genome [J]．Chin JPhysiol 1991；34： 105-120
[34]Morris AJ．Malbon CC．Physiological regulation of Gprotein linked signaling [J]．Physiol Rev 1999；79：1373-1430
[35]Bohm SK， Grady EF， Bunnet NW．Regulatory mechanisms that modulate signaling by G-protein coupled receptors[J]．BioehemJ 1997；322： 1-18
[36]Somlyo AP，Somlyo AV．Signal transduction and regulation in smooth muscle [J]．Nature 1994；372：231-236
[37]Ishihara T， Shigemoto R， Mori K．Funetional expression and tissue distribution of anovel receptor for vasoactive intestinal polypept ide [J]．Neuronl992： 8： 811-819
[38]Luta EM，Sheward WJ， Wes t．The VIP2 receptor： molecular characterization of a cDNA encoding anovel receptor vasoaative intestineal．peptide[J]．FEBS Lert 1993：334：3-8
[39]史育红，谭天秩．血管活性肠肽受体研究现状．国外医学．放射医学核医学分册[J]， 1998； 22 (4) ： 149
[40]Jin JR， Murthyks，JR，Makhlouf GM．Charaeterization of PAPCA P rceept or sand signalingPath way sinrabbit gastriemuscle cell s [J]．AlnGPhysio11997：272： G1491-1399
[41]王传晶，黄世领，龚传美，等．四逆散煎液及醇提液对四氯化碳致小白鼠肝损害的影响[J]．解放军医学高等专科学校学报，1998，26(1)：14-15
[42]付万发．邢士杰．王玉玫，等．复方四逆散冲剂与秋水仙减抗肝纤维化的临床对照研究[J]．中医药学报，1998， (6)：27-28
[43]邓银泉．四逆散加味对肝硬化实验指标改变的影响[J]．辽宁中医杂志，1996，23(2)：493
[44]王爱坚．四逆散为主治疗肝硬化腹水32例．山西中医，1999，15(2)：33
[45]赵国荣，刘近明，卢岳华，等．四逆散及其加丹参、桃仁对免疫性肝损伤大鼠ALT、 TB的影响[J]．湖南中医杂志，2000， 16(2)：55-56
[46]王虹，顾清，高建萍，等．胃起博治疗胃肠动力紊乱患者12例[J]．世界华人消化杂志，2002；10(02)：244-245
[47]林金坤，胡品津，李初俊，等．功能性消化不良胃电图与胃窦部动力[J]．中华消化杂志，2002；22(05)：315-3162．2
[48]Shiotani A，Iguchi M， Inoue 1，et al．Association between gastriec myoelectrical activity and intraluminal nitric oxide[J]．Alinlent Pharmacol Ther．2002APr； 16 Suppl2： 44-51
[49]姚永莉，张万岱，宋于刚．脾虚证与胃肠激素关系的研究[J]．新消化病学杂志，1997； 5： 728
[50]Rumessen JJ， Thuneberg L．Pacemaker cells in the gastroin testional tract：interstitial cells of Cajal [J]．Scand Gastroenterol Supp11996； 216：82-94
[51]Ward SM， Ordog T， Bayguinov JR， Horowitz B．Development Of interstitial cells of Cajal and pacemaking in mice lacking enteric nerves [J]．Gastroenterology 1999； 117：584-594
[52]郑芝田．胃肠病学[M]．第3版．北京人民卫生出版社，2000： 17-23
[53]陈崇宏，谢和辉，徐叔云．受体调节、受体与疾病[J]．中国药理学通报，1999；15：289-290
[54]吕宝璋，卢建，安明榜．受体学[M]．第1版．安徽科学技术出版社， 2000： 45-50
[55]Karoor V， Shih M， Tholanikunnel B， Malbon CC．Regulating expression and function of G-protein-linked receptors[J]．Prog Neurobiol 1996；48：555-568
[56]Malbon CC， Berrios M， Guest SJ．Signal transduction via G-protein-linked receptors：physiological regulation from the plasma membrane to the genome [J]．Chin J Physiol 1991；34： 105- 120
[57]Usdin TB， Bonner TI，Mezey E．Two receptors for vasoactive intestinal polypeptide with similar specificity and complem entary distributions．Endocrinology [J]．1994；135：2662-2679
[58]Ishihara T， Shigemoto R， Mori K．Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypept ide [J]．Neuron 1992；8： 811-819
[59]Lutz EM， Sheward WJ， West KM．The VIP2 receptor：molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide[J]．FEBS Lett 1993； 334： 3-8
[60]Grider JR， Jin JR．VIP release and L-citrulline production from isolated ganglia of the myenteric plexus evidence for regulation of VIP release by nitric oxide[J]．Neurosci 1993；54：521-526
[61]Jin JG， Murthy KS， Grider JR， Makhlouf GM．Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells[J]．Am J Physiol 1997；272：G1391-1399
[62]Altdorfer K， Bagameri G， Donath T， et al．Nitric oxidesynthase immunoreactivity of interstitial cells of Cajal in experimental colitis Inflamm[J]．Res，2002：51：569-571
[63]Kim TW， Koh SD， oxlog T， et al．Muscarinic regulation of pacemaker frequency in murine gastric interstitial cells of Cajal[J]．Physiol，2003： 546： 415-425
[64]陈元方，TADAfAKAYAMADA主编．胃肠肽类激素基础与临床[M]。第1版。北京医科大学中国协和医科大学联合出版社，1998： 71
[65]王建华，卞兆祥．脾气虚证本质研究的途径与方向[J]．中国中医药信息杂志，2000； 7 (4)： 9
[66]Sanders，KM．A case for interstitial cells of Cajal as Pacema kers and mediators of neurotransmission in the gastrointestinal traet [J]．Gastroenterology 1996，111 (2)：492-515
[67]Ward，SM， Beckett EAH，WangXY，BakerF，KhoyiM， and Sanders KM．Interstitial cells of Cajal mediate cholinergic neurotrans mission from enteric motor neurons[J]．J Neurosei2000， 20(4) 1393-1403
[68]Huizinga，JD，Thuneberg L，Kluppel M， Malysz J，Mikkelsen HB， and Bernstein A.W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity[J].Nature1995,373(6512)347-349
[69]Ward,SM,Beckett EAH,WangXY,Baker F,Khoyi M,and Sanders KM.Interstitial cells of Cajal mediate cholinergic neurotrans mission from enteric motor neurons.J Neursci 2000,20(4)1393-1403
[70]Nemeth L,Puri P.Three-dimensional morphology of C-kitpositive cellular network and nitrergic innervation in the human gut[J].Arch Pat Hoi Lab Med,2001,125(7):899
[71]HuizingaJD,WangXY,and PatersonCA.Gastric pacemaker activity And regulation of gastri c emptying:the chaotic EGG[J].Neuro gastroenterologja 2000,6:165-172
[72]MeCallum RW,George SJ.Gast roparesis[J].Clin Persp Gastro enterol 2001,4(2)147-154
[1]乔明琦．肝郁证动物模型研究的理论思考[J]．中国医药学报．1997； 12 (5)：42
[2]鄢东红．中医肝病证候去甲肾上腺和肾上腺素含量的研究[J]，湖南中医学院学报，1999； 19： (1)
[3]范恒．柴胡疏肝散加减方治疗糖尿病胃轻瘫24例[J]．中国中西医结合杂志，2002， 10(5)： 302．
[4]裴俊清，任小强，高沫莉，等．柴平汤对肝病患者胃动力及症状改善相关性研究[J]．河北中医， 2001， 17 (1 )： 5
[5]刘满君，王悦芬，陈国会．软肝方治疗肝硬化患者胃动力障碍的疗效观察[J]．河北中医，2004； 26 (8)： 575-577
[6]张北平，黄穗平．肝炎肝硬化患者的胃动力异常及“吉氏消痞方”的治疗作用[J]．广东医学杂志，2003， 24 (11)： 1166
[7]周红．胃肠舒对肝炎后肝硬化患者的胃动力障碍有较好的治疗作用[J]．四川中医．2005； 23 (3)： 27-29
[8]朱金照，许其增，王雯，等．中药白术对肝硬化大鼠肠动力及胃肠激素的影响[J]．第二军医大学学报，2005；26(11)1307-1308
[9]Jin C，Naruse S，Kitagawa M， etal．Motilin regulate sinter digestie gastric blood flow in dogs [J]．Gastroenterology，2002．123(5)：157
[1]许昌泰，闫秋枫，李玲，等．血清胃泌素，胃动素，亮-脑啡肽在肝硬化时的变化[J]．天津医药，1996， 24 (6) ： 323．
[2]陈正言，赵凯国，朱小平，等．肝硬化病人血浆胃动素水平的变化及其临床意义[J]．临床内科杂志，2000， 17 (1) ： 37．
[3]宋红丽，祝英华，刘桂梅．肝炎后肝硬化胃动力改变及胃动素检测意义[J]．医师进修杂志，2001， 24 (3) ： 14．
[4]West SD， Helmer KS， Chang CK， et al．CCK secretagogue-in-duced gastroprotection role of nitric oxide and blood flow[J]．Am JPhysiol Gastro Test Liver Physiol，2003，284(3)：G399．
[5]Paloheimo LI，Clemmesen 0， Dalhoff K， et al．Plasma cholecys-toki nin and its precursors in hepatic cirrhosis[J]．JHepatology， 1997，27：299．
[6]Cantor P．Cholecystokinin in plasma[J]．Digestion，1989，42： 181．
[7]Pompili M， Rapaccini GL， Caturelli E， et al．Gallbladder emptying， plasma levels of estradiol and progesterone， and cholecystokinin secretion in liver cirrhosis[J]．Dig Dis Sci，1995，40： 428．
[8]Grider JR，Cable MB，Said SI，et al．Vasoactive intestinal peptideas a neural mediator of gastric relaxation[J]．Am J Physiol，1985，248： G73．
[9]Simren M， Stotzer P0， Sjovall H， et al．Abnormal levels of neurope ptide Y and peptide YY in the colon in irritable bowel syn-drome [J]．Eur J Gastroenterol Hepatol，2003， 15 (1)：55．
[10]陈元方，冯子坛，阮清云，等．肝硬化患者胃肠激素的变化[J]．中华内科杂志，1987， 26 (3) ： 138．
[11]陈维雄，陈尼维，朱金小，等．肝硬化患者血浆血管活性肠肽与食管动力学关系的研究[J]．肝脏，2000， 5 (2) ： 95．
[12]王小众，张莉娟，李斌，等．门脉高压症患者生长抑素，血管活性肠肽与心钠素的检测及意义[J]．福建医科大学学报，2000， 34 (3) ： 234．
[13]Samuel S， Minta H， Zeng M， et al．Vasoactive intestinal peptidein cirrhotic rats：hemodynamic effects and mesenteric arterial re-ceptor characteristics[J]．Hepatology， 1996， 23 (5)：1174．
[14]Wang L，Zhou L．Signaltransduction pathway for antral smooth muscle cell contraction induced by motilin and gastrin in rats [J]．Sheng Li Xue Bao， 2000， 52 (4)：272．
[15]吴浩，张正，陈斌，等．钙通道活性与胃泌素促人结肠癌细胞增殖间关系的研究[J]．重庆医学，2002， 31 (4) ： 271．
[16]Winsett OE， Townsend JM， Glass EJ， et al．Gastrin stimulates growth of colon cancer [J]．Surgery， 1986，99： 302．
[17]Chowers MY， Kel ler N，Chowers Y， et al．A defined human gastrin sequence stimulates the growth of Helicobacter pylori [J]．FEMS Microbiol Lett，2002， 17(2)：231．
[18]徐秀英，赵金满，姜若兰，等．肝炎后肝硬化患者血中胃肠激素含量的变化[J]．中国医科大学学报，1995，24(5)：514．
[19]Nygreen A．Insulin uptake by human alcoholic cirrhotic liver [J]．Metabolism， 1985， 34： 48．
[20]刘超群，孙涛，李仲孝，等．乙型肝炎性肝硬化患者血浆肽类激素变化的临床观察[J]．同济医科大学学报，2001，30(4)：339．773
[21]Sanders，KM．A case for interstitial cells of Cajal as pacemakers and mddiators of neurotransmission in the gastrointertinal tract [J]．Gastroenterology 1996，111(2)：492-515
[22]Ward， SM， Beckett EAH，Wang XY，Baker F， Khoyi M， and Sanders KM．Interstitial cells of Cajal mediate cholinergic neuotrans mission from enteric motor neurons．J Neurosci 2000，20(4) 1393-1403
[23]Huizinga， JD， Thuneberg L， Kluppel M， Malysz J， Mikkel snHB， and Bernstien A．W／kit gene required for interstitial cells of Cajal and for interstial pacemaker activity[J]．Nature 1995，373 (6512)347-349
[24]高莉，秦强，赵幼安，等：肝硬化门脉高压患者胃运动功能测定的意义[J]．山东医药，2001， 41 (11) ： 38
[25]王池平，王崇奇，乔茜微，等：肝硬化患者胃排空功能与肝功能关系 的探讨[J]．中原医刊，2000， 27 (12) ： 52
[26]宗晔，王惠吉，李春林，等：肝硬化患者胃排空与小肠通过时间的研究[J]中华消化杂志，2003， 23 (6) ：352
[27]宋红丽，祝英华，刘桂梅：肝炎后肝硬化胃动力改变及胃动素检测意义[J]医师进修杂志，2001，24 (3) ： 14
[28]陈正言．肝硬化和慢性肝炎病人胃排空和胃动素的变化[J]．＆中国实验诊断学，2001， 5 (2)：57
[29]Balan KK，Grime S， Sutton R， et al．Abnormalities of gastric emptying in portal hypertension[J]．Am J Gastroent erology，1996， 91(3)530～534
[30]Dumitrascu D1，Barnert J，WiienbeckM．Gastriic emptying in liver cirrhosiS．The effect of the type of meal[J]．Eur J Gastroenterol Hepatol，1997， 9(11)：1073～1080
[31]Hongo M， Okuno Y， Yamada m， eta 1．Gastric emptying and EG[J]．Eur Gastroenterology， 1992，102：480～485
[32]许统俭，陈玉林：肝硬化患者胃电图的临床观察[J]．宁夏医学杂志，2002，23(11)：670
[33]何旭，唐晓丹，范红：肝硬化患者体表胃电图％"例分析[J]：临床消化病杂志，2001， 23 (11) ： 136
[34]吕梅：肝硬化患者胃运动障碍的胃电图观察[J]医学理论与实践，2000， 13(4)：212
[35]孙晓红，方秀才，周吕．中华医学会全国胃电图和胃肠动力研讨会纪要[J]．中华内科杂志，2002， 41 (9) ： 633．
[36]Wang ZS， ElsenbruchS， Orr WC，et al．Detection of gastrics low waveun coppling from multi-channele lectro gastrogram：validations and applications[J]．Neuogas troenterol Motil，2003， 15 (5)：457-465．
[37]王尊松，卢雪峰．肝硬化患者体表胃电图参数与肝功能损害程度的相 关性研究[J]．临床肝胆病杂志，2005， 171， 6 (21)：171-172．
[38]Sadik R，Abahamsson H， Bjornsson E， et al．Etiology of portal hapertension may in fluence gastrion test in altransit[J]．Scand J Gastroenterol，2003， 38 (10)：1039-1044．
[39]朱金照，许其增．Cajal间质细胞在胃肠动力疾病中的作用[J]．医学研究生学报，2004，17：562-564．
[40]朱金照．肝硬化大鼠肠道Cajal间质细胞的研究[J]．第二军医大学学报，2006， 27(1)65
[41]Powell DW，Mifflin RC，Valentich JD，Et al．Myofibroblasts．Ⅱ：Intestinal subepi the lial myofibrob lasts[J]．Am JPhys- iol，1999， 277： C183 C201．
[42]Nemeth L， Four cade L， Puri P．Marked morphological differences in the myentericplexus between the mesenteric and antimesen tericsides of small bowel in premature in fants[J]．Pediatr SURG， 2000， 35 (5)：748
[43]Dinan TG， Scott LV， Brady D et al．Altered hypothalamiccho liner gicre sponses in patientswits with nonulcerdy spepsia：astudy of phridostig mines timulcerdyy spepsia：astudy of pyridostig mine stimulated growth hormoner elease[J]．Am gastroentrol， 2002，97 (8)：1937
[44]DinanTG，ScottLV，Brady Detal．Altered hypothalamiccho liner gicre sponses in patientswits with nonulcerdy spepsia：astudy of phridostig mines timulcerdyy spepsia：astudy of pyridostig mine stimulated growth hormoner elease[J]．Am gastroentrol， 2002，97 (8)：193
[45]何俊堂，刘海峰，房殿春等．慢传输型便秘大鼠结肠肌间神经丛胆碱能神经及氮能神经的组化研究[J]．解放军医学杂志，2004，29(10)：854
[46]朱金照，冷恩仁，张捷．大腹皮对大鼠胃电节律紊乱的影响及机制[J]解放军医学杂志，2002，27(l)：39
[2]范云程，陈正言．胃动素测定在肝硬化诊断中的意义[J]．标记免疫分析与临床，2003， 10 (3) ：179
[3]Loui SH，Lemoine 0， Peny M0， et al．H， Lepatoprot active role of interleukin-10 in galactosamine／lipopolysac charide mouse liver injury [J]．Gastroenterology．1997， 112： 935-942．
[4]Rei tamo S， remi tz A， TamaiK， et al．Interleukin 10modulatestype Ⅰcollagen and matrix metal loprotease gene expression in cultured human skin fibro blasts [J]．Jclin Invest，1994， 94：2489-2492
[5]Gasso M， Rubio M， Varela G， et al．Effects of S-adenosylme-thionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis [J]．JHepatol，1996，25 (2)：200- 205．
[6]Rockey DC，Chung JJ．Endothelin antagonism in experimental hepatic fibrosis．Implication for endothelin in the pathogen es is of wound healing [J]．JClin Invest，1996， 98 (6)：1381-1388．
[7]Yu Q，Shao R，Qian HS， et al．Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hype r tens ion [J]．JClin Invest，2000， 105 (6)：741-748．[7]
[8]Beno DW，Mullen J， Davis BH．Lipoxygenase in hibitors block PDGF-induced mitogenesis：aMAPK-independentmechanism that block sfos and egr[J]．Am JPhysiol，1995，268 (3Pt1)：C604- C610．
[9]Levi tzki A， Gazi t A．Tyros ine kinase inhibi t ion： an approach to drug development [J]．Science，1995， 267 (5205)：1782-1788．
[10]Matsuda Y， Matsumoto K， Yamada A， et al．Preventive and thera peutic effect sinrats of hetocyte growth factor infusion on liver fibrosis／cirrhosis [J]．Hepatology， 1997，26(1)：81-89．
[11]Gandhi CR， Kuddu s R， Subbo t i n VM， e t a l．Afresh look at augmenter of liver regeneration in rats[J]．Hepatology， 1999， 29： 1435-1445．
[12]Ueki T， Kaneda Y，Tsutsui H， et al．Hepatocyte growth factor gene the rapy of liver fibrosis in rats [J]．Nat Med， 1999，5： 226-230．
[13]杨玲，抗纤软肝冲剂药物血清对激活肝星壮细胞表达I型前较原及TGF- β 1的影响[J]．中国中医基础医学杂志，2001； 7 (8)： 38
[14]王尊松．肝硬化患者体表胃电图参数与肝功能损害程度的相关性研究[J]．i临床肝胆病杂志，2005， 171， 6 (21)：171-173．
[15]Ljung T， Hellstrom PM．Vasoactive intestinal petide suppres smig ratingmyo-dectric ecomplex of rat small intestine independent of nitric oxide[J]．ActaPhysiol Scand， 1999，165 (2)：225-231．
[16]Foxx Orenstein A， Cami l leri M， Stephens D， et al．Effect of a somatostatinanalogue on gastric motor and sensory functions in healthy humans[J]．Gut， 2002， 52 (11)：1555-1561
[17]Deman JG， Chatter jee S， Dewinter BY， etal．Effect of somatostatin on gastrointestinal contractility in Schistosomamansoni infected mice [J]．Int JPar-asitol， 2002，32(10P1309-1320．
[18]魏尔清．药理学前沿一信号、蛋白因子、基因与现代药理．第1版[M]．北京：科学出版社，1999： 3-14
[19]Hanani M，Freund HR．interstitial cells of Cajal-their role in pacing and signal transmission in the digestive system[J]．Acta physiol Scand，2000：174：237-246
[20]Sanders KM， Tamas O， Koh SD， et al．A novel pacemarker mechanism drives gastrointestinal rhymicity[J]．News physiol Sci， 2000： 15： 291-298
[21]Vannunnhi MG．Receptors in interstitial cells of Cajal： Identification and possible physiological roles[J]．Microse Res Tech ．1999；47：325-335
[22]Huizing JD．Thuneberg L， Kluppep M， et al．w／kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity[J]．Nature．1995：373：347-349
[23]Komuro T， Tokui K，Zhou DS．Identification of the interstitial cells of Cajal[J]．Histopathol，1996： 11：769
[24]傅诚强 ．Cajal间质细胞控制肠动力的作用[J]，国外医学．外科学分册，1997：24(6)：323-325
[25]Sanders KM．A case for interstitial cells of Cajal as pacemakers and mediators of neurtroans mission in the gastro intestinal tract[J]．Gas troenterology， 1996： 111 (2) 492-515
[26]Plu ja L， Alberti E， Fernandez E，Mikkelsen HB，et al．Evidence supporting presence of two pace makers in rat colon[J]．Am J Physiol Gastrointest Liver Physiol，2001：281 (1)：6255-6266
[27]Wester T， Eriksson L， Olsson Y．et al．Interstital cells of Cajal in the human fetal small bowel as showm by c-kit immunohisto chemistry [J]．Gut，1999：44 (1)：65- 71
[28]Maeda H， Yamagata A， Nishikawa S， et al．Requirement of c-kit for development of intestinal pace maker system[J]．Devel opment，1992：116：369-375
[29]Kitamura Y，Hirotab S．Kit as a human oncogenic tyrosine kinase [J]．Cell Mol Life Sci，2004：61(23)：2924-2931
[30]Rumessen JJ，Vanderwinden JM．Interstitial cells in the muscula ture of the gastrointestinal tract：Ca jal and beyond [J]．Int Rev Cytol，2003：229：115-208
[31]周吕．胃肠动力与相关受体[M]．基础医学与临床2001； 21： 15
[32]Karoor V，Shih M．Tholanikunnel B，Malbon CC．Regulatingex Pression and function of G-Protein-linked receptors[J]．Prog Neurobiol 1996；48：555-568
[33]Malbon CC，Berrios M，Guest SJ．Signal transduction via G-Protein-linked receptors： Physiological regulation from the plasma membrane to the genome [J]．Chin JPhysiol 1991；34： 105-120
[34]Morris AJ．Malbon CC．Physiological regulation of Gprotein linked signaling [J]．Physiol Rev 1999；79：1373-1430
[35]Bohm SK， Grady EF， Bunnet NW．Regulatory mechanisms that modulate signaling by G-protein coupled receptors[J]．BioehemJ 1997；322： 1-18
[36]Somlyo AP，Somlyo AV．Signal transduction and regulation in smooth muscle [J]．Nature 1994；372：231-236
[37]Ishihara T， Shigemoto R， Mori K．Funetional expression and tissue distribution of anovel receptor for vasoactive intestinal polypept ide [J]．Neuronl992： 8： 811-819
[38]Luta EM，Sheward WJ， Wes t．The VIP2 receptor： molecular characterization of a cDNA encoding anovel receptor vasoaative intestineal．peptide[J]．FEBS Lert 1993：334：3-8
[39]史育红，谭天秩．血管活性肠肽受体研究现状．国外医学．放射医学核医学分册[J]， 1998； 22 (4) ： 149
[40]Jin JR， Murthyks，JR，Makhlouf GM．Charaeterization of PAPCA P rceept or sand signalingPath way sinrabbit gastriemuscle cell s [J]．AlnGPhysio11997：272： G1491-1399
[41]王传晶，黄世领，龚传美，等．四逆散煎液及醇提液对四氯化碳致小白鼠肝损害的影响[J]．解放军医学高等专科学校学报，1998，26(1)：14-15
[42]付万发．邢士杰．王玉玫，等．复方四逆散冲剂与秋水仙减抗肝纤维化的临床对照研究[J]．中医药学报，1998， (6)：27-28
[43]邓银泉．四逆散加味对肝硬化实验指标改变的影响[J]．辽宁中医杂志，1996，23(2)：493
[44]王爱坚．四逆散为主治疗肝硬化腹水32例．山西中医，1999，15(2)：33
[45]赵国荣，刘近明，卢岳华，等．四逆散及其加丹参、桃仁对免疫性肝损伤大鼠ALT、 TB的影响[J]．湖南中医杂志，2000， 16(2)：55-56
[46]王虹，顾清，高建萍，等．胃起博治疗胃肠动力紊乱患者12例[J]．世界华人消化杂志，2002；10(02)：244-245
[47]林金坤，胡品津，李初俊，等．功能性消化不良胃电图与胃窦部动力[J]．中华消化杂志，2002；22(05)：315-3162．2
[48]Shiotani A，Iguchi M， Inoue 1，et al．Association between gastriec myoelectrical activity and intraluminal nitric oxide[J]．Alinlent Pharmacol Ther．2002APr； 16 Suppl2： 44-51
[49]姚永莉，张万岱，宋于刚．脾虚证与胃肠激素关系的研究[J]．新消化病学杂志，1997； 5： 728
[50]Rumessen JJ， Thuneberg L．Pacemaker cells in the gastroin testional tract：interstitial cells of Cajal [J]．Scand Gastroenterol Supp11996； 216：82-94
[51]Ward SM， Ordog T， Bayguinov JR， Horowitz B．Development Of interstitial cells of Cajal and pacemaking in mice lacking enteric nerves [J]．Gastroenterology 1999； 117：584-594
[52]郑芝田．胃肠病学[M]．第3版．北京人民卫生出版社，2000： 17-23
[53]陈崇宏，谢和辉，徐叔云．受体调节、受体与疾病[J]．中国药理学通报，1999；15：289-290
[54]吕宝璋，卢建，安明榜．受体学[M]．第1版．安徽科学技术出版社， 2000： 45-50
[55]Karoor V， Shih M， Tholanikunnel B， Malbon CC．Regulating expression and function of G-protein-linked receptors[J]．Prog Neurobiol 1996；48：555-568
[56]Malbon CC， Berrios M， Guest SJ．Signal transduction via G-protein-linked receptors：physiological regulation from the plasma membrane to the genome [J]．Chin J Physiol 1991；34： 105- 120
[57]Usdin TB， Bonner TI，Mezey E．Two receptors for vasoactive intestinal polypeptide with similar specificity and complem entary distributions．Endocrinology [J]．1994；135：2662-2679
[58]Ishihara T， Shigemoto R， Mori K．Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypept ide [J]．Neuron 1992；8： 811-819
[59]Lutz EM， Sheward WJ， West KM．The VIP2 receptor：molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide[J]．FEBS Lett 1993； 334： 3-8
[60]Grider JR， Jin JR．VIP release and L-citrulline production from isolated ganglia of the myenteric plexus evidence for regulation of VIP release by nitric oxide[J]．Neurosci 1993；54：521-526
[61]Jin JG， Murthy KS， Grider JR， Makhlouf GM．Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells[J]．Am J Physiol 1997；272：G1391-1399
[62]Altdorfer K， Bagameri G， Donath T， et al．Nitric oxidesynthase immunoreactivity of interstitial cells of Cajal in experimental colitis Inflamm[J]．Res，2002：51：569-571
[63]Kim TW， Koh SD， oxlog T， et al．Muscarinic regulation of pacemaker frequency in murine gastric interstitial cells of Cajal[J]．Physiol，2003： 546： 415-425
[64]陈元方，TADAfAKAYAMADA主编．胃肠肽类激素基础与临床[M]。第1版。北京医科大学中国协和医科大学联合出版社，1998： 71
[65]王建华，卞兆祥．脾气虚证本质研究的途径与方向[J]．中国中医药信息杂志，2000； 7 (4)： 9
[66]Sanders，KM．A case for interstitial cells of Cajal as Pacema kers and mediators of neurotransmission in the gastrointestinal traet [J]．Gastroenterology 1996，111 (2)：492-515
[67]Ward，SM， Beckett EAH，WangXY，BakerF，KhoyiM， and Sanders KM．Interstitial cells of Cajal mediate cholinergic neurotrans mission from enteric motor neurons[J]．J Neurosei2000， 20(4) 1393-1403
[68]Huizinga，JD，Thuneberg L，Kluppel M， Malysz J，Mikkelsen HB， and Bernstein A.W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity[J].Nature1995,373(6512)347-349
[69]Ward,SM,Beckett EAH,WangXY,Baker F,Khoyi M,and Sanders KM.Interstitial cells of Cajal mediate cholinergic neurotrans mission from enteric motor neurons.J Neursci 2000,20(4)1393-1403
[70]Nemeth L,Puri P.Three-dimensional morphology of C-kitpositive cellular network and nitrergic innervation in the human gut[J].Arch Pat Hoi Lab Med,2001,125(7):899
[71]HuizingaJD,WangXY,and PatersonCA.Gastric pacemaker activity And regulation of gastri c emptying:the chaotic EGG[J].Neuro gastroenterologja 2000,6:165-172
[72]MeCallum RW,George SJ.Gast roparesis[J].Clin Persp Gastro enterol 2001,4(2)147-154
[1]乔明琦．肝郁证动物模型研究的理论思考[J]．中国医药学报．1997； 12 (5)：42
[2]鄢东红．中医肝病证候去甲肾上腺和肾上腺素含量的研究[J]，湖南中医学院学报，1999； 19： (1)
[3]范恒．柴胡疏肝散加减方治疗糖尿病胃轻瘫24例[J]．中国中西医结合杂志，2002， 10(5)： 302．
[4]裴俊清，任小强，高沫莉，等．柴平汤对肝病患者胃动力及症状改善相关性研究[J]．河北中医， 2001， 17 (1 )： 5
[5]刘满君，王悦芬，陈国会．软肝方治疗肝硬化患者胃动力障碍的疗效观察[J]．河北中医，2004； 26 (8)： 575-577
[6]张北平，黄穗平．肝炎肝硬化患者的胃动力异常及“吉氏消痞方”的治疗作用[J]．广东医学杂志，2003， 24 (11)： 1166
[7]周红．胃肠舒对肝炎后肝硬化患者的胃动力障碍有较好的治疗作用[J]．四川中医．2005； 23 (3)： 27-29
[8]朱金照，许其增，王雯，等．中药白术对肝硬化大鼠肠动力及胃肠激素的影响[J]．第二军医大学学报，2005；26(11)1307-1308
[9]Jin C，Naruse S，Kitagawa M， etal．Motilin regulate sinter digestie gastric blood flow in dogs [J]．Gastroenterology，2002．123(5)：157
[1]许昌泰，闫秋枫，李玲，等．血清胃泌素，胃动素，亮-脑啡肽在肝硬化时的变化[J]．天津医药，1996， 24 (6) ： 323．
[2]陈正言，赵凯国，朱小平，等．肝硬化病人血浆胃动素水平的变化及其临床意义[J]．临床内科杂志，2000， 17 (1) ： 37．
[3]宋红丽，祝英华，刘桂梅．肝炎后肝硬化胃动力改变及胃动素检测意义[J]．医师进修杂志，2001， 24 (3) ： 14．
[4]West SD， Helmer KS， Chang CK， et al．CCK secretagogue-in-duced gastroprotection role of nitric oxide and blood flow[J]．Am JPhysiol Gastro Test Liver Physiol，2003，284(3)：G399．
[5]Paloheimo LI，Clemmesen 0， Dalhoff K， et al．Plasma cholecys-toki nin and its precursors in hepatic cirrhosis[J]．JHepatology， 1997，27：299．
[6]Cantor P．Cholecystokinin in plasma[J]．Digestion，1989，42： 181．
[7]Pompili M， Rapaccini GL， Caturelli E， et al．Gallbladder emptying， plasma levels of estradiol and progesterone， and cholecystokinin secretion in liver cirrhosis[J]．Dig Dis Sci，1995，40： 428．
[8]Grider JR，Cable MB，Said SI，et al．Vasoactive intestinal peptideas a neural mediator of gastric relaxation[J]．Am J Physiol，1985，248： G73．
[9]Simren M， Stotzer P0， Sjovall H， et al．Abnormal levels of neurope ptide Y and peptide YY in the colon in irritable bowel syn-drome [J]．Eur J Gastroenterol Hepatol，2003， 15 (1)：55．
[10]陈元方，冯子坛，阮清云，等．肝硬化患者胃肠激素的变化[J]．中华内科杂志，1987， 26 (3) ： 138．
[11]陈维雄，陈尼维，朱金小，等．肝硬化患者血浆血管活性肠肽与食管动力学关系的研究[J]．肝脏，2000， 5 (2) ： 95．
[12]王小众，张莉娟，李斌，等．门脉高压症患者生长抑素，血管活性肠肽与心钠素的检测及意义[J]．福建医科大学学报，2000， 34 (3) ： 234．
[13]Samuel S， Minta H， Zeng M， et al．Vasoactive intestinal peptidein cirrhotic rats：hemodynamic effects and mesenteric arterial re-ceptor characteristics[J]．Hepatology， 1996， 23 (5)：1174．
[14]Wang L，Zhou L．Signaltransduction pathway for antral smooth muscle cell contraction induced by motilin and gastrin in rats [J]．Sheng Li Xue Bao， 2000， 52 (4)：272．
[15]吴浩，张正，陈斌，等．钙通道活性与胃泌素促人结肠癌细胞增殖间关系的研究[J]．重庆医学，2002， 31 (4) ： 271．
[16]Winsett OE， Townsend JM， Glass EJ， et al．Gastrin stimulates growth of colon cancer [J]．Surgery， 1986，99： 302．
[17]Chowers MY， Kel ler N，Chowers Y， et al．A defined human gastrin sequence stimulates the growth of Helicobacter pylori [J]．FEMS Microbiol Lett，2002， 17(2)：231．
[18]徐秀英，赵金满，姜若兰，等．肝炎后肝硬化患者血中胃肠激素含量的变化[J]．中国医科大学学报，1995，24(5)：514．
[19]Nygreen A．Insulin uptake by human alcoholic cirrhotic liver [J]．Metabolism， 1985， 34： 48．
[20]刘超群，孙涛，李仲孝，等．乙型肝炎性肝硬化患者血浆肽类激素变化的临床观察[J]．同济医科大学学报，2001，30(4)：339．773
[21]Sanders，KM．A case for interstitial cells of Cajal as pacemakers and mddiators of neurotransmission in the gastrointertinal tract [J]．Gastroenterology 1996，111(2)：492-515
[22]Ward， SM， Beckett EAH，Wang XY，Baker F， Khoyi M， and Sanders KM．Interstitial cells of Cajal mediate cholinergic neuotrans mission from enteric motor neurons．J Neurosci 2000，20(4) 1393-1403
[23]Huizinga， JD， Thuneberg L， Kluppel M， Malysz J， Mikkel snHB， and Bernstien A．W／kit gene required for interstitial cells of Cajal and for interstial pacemaker activity[J]．Nature 1995，373 (6512)347-349
[24]高莉，秦强，赵幼安，等：肝硬化门脉高压患者胃运动功能测定的意义[J]．山东医药，2001， 41 (11) ： 38
[25]王池平，王崇奇，乔茜微，等：肝硬化患者胃排空功能与肝功能关系 的探讨[J]．中原医刊，2000， 27 (12) ： 52
[26]宗晔，王惠吉，李春林，等：肝硬化患者胃排空与小肠通过时间的研究[J]中华消化杂志，2003， 23 (6) ：352
[27]宋红丽，祝英华，刘桂梅：肝炎后肝硬化胃动力改变及胃动素检测意义[J]医师进修杂志，2001，24 (3) ： 14
[28]陈正言．肝硬化和慢性肝炎病人胃排空和胃动素的变化[J]．＆中国实验诊断学，2001， 5 (2)：57
[29]Balan KK，Grime S， Sutton R， et al．Abnormalities of gastric emptying in portal hypertension[J]．Am J Gastroent erology，1996， 91(3)530～534
[30]Dumitrascu D1，Barnert J，WiienbeckM．Gastriic emptying in liver cirrhosiS．The effect of the type of meal[J]．Eur J Gastroenterol Hepatol，1997， 9(11)：1073～1080
[31]Hongo M， Okuno Y， Yamada m， eta 1．Gastric emptying and EG[J]．Eur Gastroenterology， 1992，102：480～485
[32]许统俭，陈玉林：肝硬化患者胃电图的临床观察[J]．宁夏医学杂志，2002，23(11)：670
[33]何旭，唐晓丹，范红：肝硬化患者体表胃电图％"例分析[J]：临床消化病杂志，2001， 23 (11) ： 136
[34]吕梅：肝硬化患者胃运动障碍的胃电图观察[J]医学理论与实践，2000， 13(4)：212
[35]孙晓红，方秀才，周吕．中华医学会全国胃电图和胃肠动力研讨会纪要[J]．中华内科杂志，2002， 41 (9) ： 633．
[36]Wang ZS， ElsenbruchS， Orr WC，et al．Detection of gastrics low waveun coppling from multi-channele lectro gastrogram：validations and applications[J]．Neuogas troenterol Motil，2003， 15 (5)：457-465．
[37]王尊松，卢雪峰．肝硬化患者体表胃电图参数与肝功能损害程度的相 关性研究[J]．临床肝胆病杂志，2005， 171， 6 (21)：171-172．
[38]Sadik R，Abahamsson H， Bjornsson E， et al．Etiology of portal hapertension may in fluence gastrion test in altransit[J]．Scand J Gastroenterol，2003， 38 (10)：1039-1044．
[39]朱金照，许其增．Cajal间质细胞在胃肠动力疾病中的作用[J]．医学研究生学报，2004，17：562-564．
[40]朱金照．肝硬化大鼠肠道Cajal间质细胞的研究[J]．第二军医大学学报，2006， 27(1)65
[41]Powell DW，Mifflin RC，Valentich JD，Et al．Myofibroblasts．Ⅱ：Intestinal subepi the lial myofibrob lasts[J]．Am JPhys- iol，1999， 277： C183 C201．
[42]Nemeth L， Four cade L， Puri P．Marked morphological differences in the myentericplexus between the mesenteric and antimesen tericsides of small bowel in premature in fants[J]．Pediatr SURG， 2000， 35 (5)：748
[43]Dinan TG， Scott LV， Brady D et al．Altered hypothalamiccho liner gicre sponses in patientswits with nonulcerdy spepsia：astudy of phridostig mines timulcerdyy spepsia：astudy of pyridostig mine stimulated growth hormoner elease[J]．Am gastroentrol， 2002，97 (8)：1937
[44]DinanTG，ScottLV，Brady Detal．Altered hypothalamiccho liner gicre sponses in patientswits with nonulcerdy spepsia：astudy of phridostig mines timulcerdyy spepsia：astudy of pyridostig mine stimulated growth hormoner elease[J]．Am gastroentrol， 2002，97 (8)：193
[45]何俊堂，刘海峰，房殿春等．慢传输型便秘大鼠结肠肌间神经丛胆碱能神经及氮能神经的组化研究[J]．解放军医学杂志，2004，29(10)：854
[46]朱金照，冷恩仁，张捷．大腹皮对大鼠胃电节律紊乱的影响及机制[J]解放军医学杂志，2002，27(l)：39
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |